A citation-based method for searching scientific literature

Amy C Plint, David Moher, Andra Morrison, Kenneth Schulz, Douglas G Altman, Catherine Hill, Isabelle Gaboury. Med J Aust 2006
Times Cited: 552







List of co-cited articles
688 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.
Lucy Turner, Larissa Shamseer, Douglas G Altman, Laura Weeks, Jodi Peters, Thilo Kober, Sofia Dias, Kenneth F Schulz, Amy C Plint, David Moher. Cochrane Database Syst Rev 2012
408
24

CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.
David Moher, Sally Hopewell, Kenneth F Schulz, Victor Montori, Peter C Gøtzsche, P J Devereaux, Diana Elbourne, Matthias Egger, Douglas G Altman. BMJ 2010
23



The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed.
Sally Hopewell, Susan Dutton, Ly-Mee Yu, An-Wen Chan, Douglas G Altman. BMJ 2010
331
19


Guidance for developers of health research reporting guidelines.
David Moher, Kenneth F Schulz, Iveta Simera, Douglas G Altman. PLoS Med 2010
536
15

Reducing waste from incomplete or unusable reports of biomedical research.
Paul Glasziou, Douglas G Altman, Patrick Bossuyt, Isabelle Boutron, Mike Clarke, Steven Julious, Susan Michie, David Moher, Elizabeth Wager. Lancet 2014
632
13

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
12

Improving the quality of reporting of randomized controlled trials. The CONSORT statement.
C Begg, M Cho, S Eastwood, R Horton, D Moher, I Olkin, R Pitkin, D Rennie, K F Schulz, D Simel,[...]. JAMA 1996
12

The quality of diagnostic accuracy studies since the STARD statement: has it improved?
N Smidt, A W S Rutjes, D A W M van der Windt, R W J G Ostelo, P M Bossuyt, J B Reitsma, L M Bouter, H C W de Vet. Neurology 2006
181
12

A systematic scoping review of adherence to reporting guidelines in health care literature.
Zainab Samaan, Lawrence Mbuagbaw, Daisy Kosa, Victoria Borg Debono, Rejane Dillenburg, Shiyuan Zhang, Vincent Fruci, Brittany Dennis, Monica Bawor, Lehana Thabane. J Multidiscip Healthc 2013
99
11

Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide.
Tammy C Hoffmann, Paul P Glasziou, Isabelle Boutron, Ruairidh Milne, Rafael Perera, David Moher, Douglas G Altman, Virginia Barbour, Helen Macdonald, Marie Johnston,[...]. BMJ 2014
10


Reporting in randomized clinical trials improved after adoption of the CONSORT statement.
Robert L Kane, Jye Wang, Judith Garrard. J Clin Epidemiol 2007
145
10

Effect of using reporting guidelines during peer review on quality of final manuscripts submitted to a biomedical journal: masked randomised trial.
E Cobo, J Cortés, J M Ribera, F Cardellach, A Selva-O'Callaghan, B Kostov, L García, L Cirugeda, D G Altman, J A González,[...]. BMJ 2011
153
10

STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies.
Patrick M Bossuyt, Johannes B Reitsma, David E Bruns, Constantine A Gatsonis, Paul P Glasziou, Les Irwig, Jeroen G Lijmer, David Moher, Drummond Rennie, Henrica C W de Vet,[...]. BMJ 2015
9

Update on the endorsement of CONSORT by high impact factor journals: a survey of journal "Instructions to Authors" in 2014.
Larissa Shamseer, Sally Hopewell, Douglas G Altman, David Moher, Kenneth F Schulz. Trials 2016
61
13

Consort 2010 statement: extension to cluster randomised trials.
Marion K Campbell, Gilda Piaggio, Diana R Elbourne, Douglas G Altman. BMJ 2012
969
8



Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. Ann Intern Med 2009
8


The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
Julian P T Higgins, Douglas G Altman, Peter C Gøtzsche, Peter Jüni, David Moher, Andrew D Oxman, Jelena Savovic, Kenneth F Schulz, Laura Weeks, Jonathan A C Sterne. BMJ 2011
8

A systematic evaluation of the impact of STRICTA and CONSORT recommendations on quality of reporting for acupuncture trials.
Stephanie L Prady, Stewart J Richmond, Veronica M Morton, Hugh Macpherson. PLoS One 2008
105
8


Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. BMJ 2009
8

CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.
Kenneth F Schulz, Douglas G Altman, David Moher. Ann Intern Med 2010
8



What is missing from descriptions of treatment in trials and reviews?
Paul Glasziou, Emma Meats, Carl Heneghan, Sasha Shepperd. BMJ 2008
385
7

EQUATOR: reporting guidelines for health research.
Douglas G Altman, Iveta Simera, John Hoey, David Moher, Ken Schulz. Lancet 2008
131
7

CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts.
Isabelle Boutron, Douglas G Altman, David Moher, Kenneth F Schulz, Philippe Ravaud. Ann Intern Med 2017
393
7


Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study.
Agnes Dechartres, Ludovic Trinquart, Ignacio Atal, David Moher, Kay Dickersin, Isabelle Boutron, Elodie Perrodeau, Douglas G Altman, Philippe Ravaud. BMJ 2017
63
11

Impact of the mandatory implementation of reporting guidelines on reporting quality in a surgical journal: A before and after study.
Riaz Ahmed Agha, Alexander J Fowler, Christopher Limb, Katharine Whitehurst, Robert Coe, Harkiran Sagoo, Daniyal J Jafree, Charmilie Chandrakumar, Buket Gundogan. Int J Surg 2016
35
20

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
D Moher, B Pham, A Jones, D J Cook, A R Jadad, M Moher, P Tugwell, T P Klassen. Lancet 1998
7


Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research.
Carol Kilkenny, William J Browne, Innes C Cuthill, Michael Emerson, Douglas G Altman. PLoS Biol 2010
6

Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension.
Melanie Calvert, Jane Blazeby, Douglas G Altman, Dennis A Revicki, David Moher, Michael D Brundage. JAMA 2013
598
6

Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement.
Gilda Piaggio, Diana R Elbourne, Stuart J Pocock, Stephen J W Evans, Douglas G Altman. JAMA 2012
664
6

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.
An-Wen Chan, Jennifer M Tetzlaff, Peter C Gøtzsche, Douglas G Altman, Howard Mann, Jesse A Berlin, Kay Dickersin, Asbjørn Hróbjartsson, Kenneth F Schulz, Wendy R Parulekar,[...]. BMJ 2013
6

Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial.
Caroline Barnes, Isabelle Boutron, Bruno Giraudeau, Raphael Porcher, Douglas G Altman, Philippe Ravaud. BMC Med 2015
54
11

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.
Jan P Vandenbroucke, Erik von Elm, Douglas G Altman, Peter C Gøtzsche, Cynthia D Mulrow, Stuart J Pocock, Charles Poole, James J Schlesselman, Matthias Egger. PLoS Med 2007
6


Better reporting of harms in randomized trials: an extension of the CONSORT statement.
John P A Ioannidis, Stephen J W Evans, Peter C Gøtzsche, Robert T O'Neill, Douglas G Altman, Kenneth Schulz, David Moher. Ann Intern Med 2004
903
6


Guidelines for the Content of Statistical Analysis Plans in Clinical Trials.
Carrol Gamble, Ashma Krishan, Deborah Stocken, Steff Lewis, Edmund Juszczak, Caroline Doré, Paula R Williamson, Douglas G Altman, Alan Montgomery, Pilar Lim,[...]. JAMA 2017
123
6

Assessing the quality of reports of randomized clinical trials: is blinding necessary?
A R Jadad, R A Moore, D Carroll, C Jenkinson, D J Reynolds, D J Gavaghan, H J McQuay. Control Clin Trials 1996
5

Quality of reporting of modern randomized controlled trials in medical oncology: a systematic review.
Julien Péron, Gregory R Pond, Hui K Gan, Eric X Chen, Roula Almufti, Denis Maillet, Benoit You. J Natl Cancer Inst 2012
70
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.